The COVID-19 pandemic raises another mysterious problem with several patients taking Pfizer’s COVID antiviral drug, Paxrovid, who are initially feeling better and then experiencing rebound symptoms....
recently Review of medical virology In the article, scientists discuss the pathogenic characteristics of coronavirus 2 (SARS-CoV-2) and the therapeutic interventions available to treat coronavirus disease...
(CNN)-Merck’s COVID-19 pill seems to help people leave the hospital. A new study in India found that treatment with molnupiravir, an antiviral drug from a pharmaceutical...
In a recent study published in New England Journal of Medicine, A team of Pfizer researchers in the United States (US) have found the efficacy and...
Pfizer tablet trials are very promising, with a 89% reduction in the risk of hospitalization in mild to moderate Covid-19 adults who are at high risk...
The 2019 coronavirus disease (COVID-19) pandemic was caused by a new coronavirus, Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2). As a result of the continued efforts of...
Recent Comments